Deutsche Bank set a €62.00 ($72.09) target price on Compugroup Medical (ETR:COP) in a research note published on Tuesday morning. The firm currently has a buy rating on the stock.

Other research analysts have also issued research reports about the company. Warburg Research set a €53.50 ($62.21) price objective on Compugroup Medical and gave the company a buy rating in a research report on Friday, August 10th. Commerzbank set a €53.00 ($61.63) price objective on Compugroup Medical and gave the company a buy rating in a research report on Monday, October 22nd. Baader Bank set a €46.00 ($53.49) price objective on Compugroup Medical and gave the company a neutral rating in a research report on Thursday, August 9th. Finally, Berenberg Bank set a €49.00 ($56.98) price objective on Compugroup Medical and gave the company a neutral rating in a research report on Monday, August 13th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the stock. The stock presently has a consensus rating of Hold and an average target price of €51.79 ($60.22).

Shares of Compugroup Medical stock opened at €43.12 ($50.14) on Tuesday. Compugroup Medical has a twelve month low of €40.10 ($46.63) and a twelve month high of €60.30 ($70.12).

Compugroup Medical Company Profile

CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.

Featured Story: Market Capitalization

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.